Abstract
NRIF3 is an estrogen-inducible nuclear receptor coregulator that stimulates estrogen receptor-α (ERα) transactivation functions and associates with the endogenous ER and its target gene promoter. p21-activated protein kinase 1 (Pak1) phosphorylates ERα at Ser305 and this modification is important in ERα transactivation function. Although ERα transactivation functions are regulated by co-activator activity of NRIF3, it remains unclear whether Pak1 could impact ER functions via a posttranslational modification of NRIF3. Here, we report that Pak1 phosphorylates NRIF3 at Serine28 and that NRIF3 binds to Pak1 in vitro and in vivo. We found that NRIF3 phosphorylation, co-activator activity and association with ERα increased following Pak1 phosphorylation of NRIF3's Ser28 and that activated ERα-Ser305 and NRIF3-Ser28 cooperatively support transactivation of ERα. NRIF3 expression increased significantly in cells with inducible Pak1 expression. We found that NRIF3 and ERα interaction, subcellular localization and ERα transactivation activity all increased in cells expressing the Pak1 phosphorylation-mimicking mutant NRIF3-Ser28Glu. Consistently, the NRIF3-Ser28Glu mutant exhibited an enhanced recruitment to the endogenous ER target genes and increased expression following estrogen stimulation. Finally, breast cancer cells with stable overexpression of NRIF3 showed increased proliferation and enhanced anchorage-independent growth. These findings suggest that NRIF3-Ser28 is a physiologic target of Pak1 signaling and contributes to the enhanced NRIF3 co-activator activity, leading to coordinated potentiation of ERα transactivation, its target gene expression and estrogen responsiveness of breast cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- E2:
-
17-β-estrodiol
- ER:
-
estrogen receptor-α
- ERE:
-
estrogen response element
- luc:
-
luciferase
- MTA1:
-
metastasis tumor antigen1
- NR:
-
nuclear receptor
References
Ali S, Metzger D, Bornert JM, Chambon P . (1993). Phosphorylation of the human oestrogen receptor: identification of a phosphorylation site required for trans-activation. EMBO J 12: 1153–1160.
Arnold SF, Obourn JD, Jaffe H, Notides AC . (1994). Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol Endocrinol 8: 1208–1214.
Arnold SF, Obourn JD, Jaffe H, Notides AC . (1995a). Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J Steroid Biochem Mol Biol 55: 163–172.
Arnold SF, Obourn JD, Jaffe H, Notides AC . (1995b). Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol Endocrinol 9: 24–33.
Arnold SF, Obourn JD, Yudt MR, Carter TH, Notides AC . (1995c). In vivo and in vitro phosphorylation of the human estrogen receptor. J Steroid Biochem Mol Biol 52: 159–171.
Aronica SM, Katzenellenbogen BS . (1993). Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclin adenosine monophosphate and insulin-like growth factor-1. Mol Endocrinol 7: 743–752.
Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK et al. (2004). p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279: 1422–1428.
Bunone G, Briand PA, Miksicek RJ, Picard D . (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15: 2174–2183.
Castoria G, Migliaccio A, Green S, Di-Domenico M, Chambon P, Aurrichio F . (1993). Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 32: 1740–1750.
Font de Mora J, Brown M . (2000). AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20: 5041–5047.
Freedman LP . (1999). Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97: 5–8.
Glass CK, Rosenfeld MG . (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121–141.
Hermanson O, Glass CK, Rosenfeld MG . (2002). Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13: 55–60.
Ignar-Trowbridge D, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA . (1993). Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7: 992–998.
Joel PB, Traish AM, Lannigan DA . (1995). Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9: 1041–1052.
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403–414.
Kato S, Endoh E, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491–14941.
Kumar R, Vadlamudi RK . (2002). Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 193: 133–144.
Lazaro JB, Bailey PJ, Lassar AB . (2002). Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev 16: 1792–1805.
Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS . (1994). Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269: 4458–4466.
Li D, Desai-Yajnik V, Lo E, Schapira M, Abagyan R, Samuels HH . (1999). NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol Cell Biol 19: 7191–7202.
Li D, Wang F, Samuels HH . (2001). Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation. Mol Cell Biol 21: 8371–8384.
Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A . (1994). Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 8: 910–918.
Metzger D, Berry M, Ali S, Chambon P . (1995). Effect of antagonists on DNA binding properties of the human oestrogen receptor in vitro and in vivo. Mol Endocrinol 9: 579–591.
Onate SA, Tsai SY, Tsai MJ, O'Malley BW . (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354–1357.
Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A . (1996). Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 10: 499–507.
Pierce KL, Luttrell LM, Lefkowitz RJ . (2001). New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532–1539.
Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pelgram MD, Ramos L et al. (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10: 2435–2446.
Rowan BG, Garrison N, Weigel NL, O'Malley BW . (2000). 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol 20: 8720–8730.
Spiegelman BM, Heinrich R . (2004). Biological control through regulated transcriptional coactivators. Cell 119: 157–167.
Talukder AH, Gururaj A, Mishra SK, Vadlamudi RK, Kumar R . (2004). Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Mol Cell Biol 24: 6581–6591.
Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A et al. (2000). Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275: 36238–36244.
Wang RA, Mazumdar A, Vadlamudi RK, Kumar R . (2002). P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J 21: 5437–5447.
Wang Z, Rose DW, Hermanson O, Liu F, Herman T, Wu W et al. (2000). Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci USA 97: 13549–13554.
Wu RC, Qin J, Hashimoto Y, Wong J, Xu J, Tsai SY et al. (2002). Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by IκB kinase. Mol Cell Biol 22: 3549–3561.
Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ et al. (2004). Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15: 937–949.
Wu RC, Smith CL, O'Malley BW . (2005). Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26: 393–399.
Acknowledgements
We thank Christopher J Barnes and Suresh Rayala for the confocal microscopy and western blotting, respectively. This study was supported by the NIH grants CA90970 and CA098823 to RK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Talukder, A., Li, DQ., Manavathi, B. et al. Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-α transactivation. Oncogene 27, 5233–5242 (2008). https://doi.org/10.1038/onc.2008.151
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.151
Keywords
This article is cited by
-
Sex-dependent dominance maintains migration supergene in rainbow trout
Nature Ecology & Evolution (2019)
-
ER and PR signaling nodes during mammary gland development
Breast Cancer Research (2012)